• 2016
  Connell BJ, Sadir R, Baleux F, Laguri C, Kleman JP, Luo L, Arenzana-Seisdedos F, Lortat-Jacob H, Heparan sulfate differentially controls CXCL12α- and CXCL12γ-mediated cell migration through differential presentation to their receptor CXCR4, Sci Signal 2016 Nov;9(452):ra107.
• 2016
  Ariën KK, Baleux F, Desjardins D, Porrot F, Coïc YM, Michiels J, Bouchemal K, Bonnaffé D, Bruel T, Schwartz O, Le Grand R, Vanham G, Dereuddre-Bosquet N, Lortat-Jacob H, CD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challenge, Sci Rep 2016 Oct;6:34829.
• 2014
  Migliorini E, Thakar D, Sadir R, Pleiner T, Baleux F, Lortat-Jacob H, Coche-Guerente L, Richter RP, Well-defined biomimetic surfaces to characterize glycosaminoglycan-mediated interactions on the molecular, supramolecular and cellular levels, Biomaterials 2014 Oct;35(32):8903-15.
• 2013
  Noya V, Bay S, Festari MF, García EP, Rodriguez E, Chiale C, Ganneau C, Baleux F, Astrada S, Bollati-Fogolín M, Osinaga E, Freire T, Mucin-like peptides from Echinococcus granulosus induce antitumor activity, Int. J. Oncol. 2013 Sep;43(3):775-84.
• 2012
  Rueda P, Richart A, Récalde A, Gasse P, Vilar J, Guérin C, Lortat-Jacob H, Vieira P, Baleux F, Chretien F, Arenzana-Seisdedos F, Silvestre JS, Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions, Circulation 2012 Oct;126(15):1882-95.
• 2012
  Denoyer A, Godefroy D, Célérier I, Frugier J, Degardin J, Harrison JK, Brignole-Baudouin F, Picaud S, Baleux F, Sahel JA, Rostène W, Baudouin C, CXCR3 antagonism of SDF-1(5-67) restores trabecular function and prevents retinal neurodegeneration in a rat model of ocular hypertension, PLoS ONE 2012;7(6):e37873.
• 2012
  Coïc YM, Baleux F, Poyraz Ö, Thibeaux R, Labruyere E, Chretien F, Sobhani I, Lazure T, Wyplosz B, Schneider G, Mulard L, Sansonetti PJ, Marteyn BS, Design of a specific colonic mucus marker using a human commensal bacterium cell surface domain, J. Biol. Chem. 2012 May;287(19):15916-22.
• 2012
  Connell BJ, Baleux F, Coic YM, Clayette P, Bonnaffé D, Lortat-Jacob H, A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti- HIV-1 activity independently of coreceptor usage, Chem. Biol. 2012 Jan;19(1):131-9.
• 2011
  Chiaravalli J, Fontan E, Fsihi H, Coic YM, Baleux F, Véron M, Agou F, Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO, Biochem. Pharmacol. 2011 Nov;82(9):1163-74.
• 2011
  Dar A, Schajnovitz A, Lapid K, Kalinkovich A, Itkin T, Ludin A, Kao WM, Battista M, Tesio M, Kollet O, Cohen NN, Margalit R, Buss EC, Baleux F, Oishi S, Fujii N, Larochelle A, Dunbar CE, Broxmeyer HE, Frenette PS, Lapidot T, Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells, Leukemia 2011 Aug;25(8):1286-96.
• 2010
  Coïc YM, Lan CL, Neumann JM, Jamin N, Baleux F, Slightly modifying pseudoproline dipeptides incorporation strategy enables solid phase synthesis of a 54 AA fragment of caveolin-1 encompassing the intramembrane domain, J. Pept. Sci. 2010 Feb;16(2):98-104.
• 2009
  Baleux F, Loureiro-Morais L, Hersant Y, Clayette P, Arenzana-Seisdedos F, Bonnaffé D, Lortat-Jacob H, A synthetic CD4-heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry, Nat. Chem. Biol. 2009 Oct;5(10):743-8.
• 2009
  Friand V, Haddad O, Papy-Garcia D, Hlawaty H, Vassy R, Hamma-Kourbali Y, Perret GY, Courty J, Baleux F, Oudar O, Gattegno L, Sutton A, Charnaux N, Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells, Glycobiology 2009 Dec;19(12):1511-24.
• 2009
  Brule S, Friand V, Sutton A, Baleux F, Gattegno L, Charnaux N, Glycosaminoglycans and syndecan-4 are involved in SDF-1/CXCL12-mediated invasion of human epitheloid carcinoma HeLa cells, Biochim. Biophys. Acta 2009 Dec;1790(12):1643-50.
• 2009
  Levoye A, Balabanian K, Baleux F, Bachelerie F, Lagane B, CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling, Blood 2009 Jun;113(24):6085-93.
• 2008
  Fermas S, Gonnet F, Sutton A, Charnaux N, Mulloy B, Du Y, Baleux F, Daniel R, Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis, Glycobiology 2008 Dec;18(12):1054-64.
• 2008
  Rueda P, Balabanian K, Lagane B, Staropoli I, Chow K, Levoye A, Laguri C, Sadir R, Delaunay T, Izquierdo E, Pablos JL, Lendinez E, Caruz A, Franco D, Baleux F, Lortat-Jacob H, Arenzana-Seisdedos F, The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins, PLoS ONE 2008;3(7):e2543.
• 2008
  Hachet-Haas M, Balabanian K, Rohmer F, Pons F, Franchet C, Lecat S, Chow KY, Dagher R, Gizzi P, Didier B, Lagane B, Kellenberger E, Bonnet D, Baleux F, Haiech J, Parmentier M, Frossard N, Arenzana-Seisdedos F, Hibert M, Galzi JL, Small neutralizing molecules to inhibit actions of the chemokine CXCL12, J. Biol. Chem. 2008 Aug;283(34):23189-99.
• 2008
  Lagane B, Chow KY, Balabanian K, Levoye A, Harriague J, Planchenault T, Baleux F, Gunera-Saad N, Arenzana-Seisdedos F, Bachelerie F, CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome, Blood 2008 Jul;112(1):34-44.
• 2008
  Mercey E, Sadir R, Maillart E, Roget A, Baleux F, Lortat-Jacob H, Livache T, Polypyrrole oligosaccharide array and surface plasmon resonance imaging for the measurement of glycosaminoglycan binding interactions, Anal. Chem. 2008 May;80(9):3476-82.
• 2008
  Balabanian K, Levoye A, Klemm L, Lagane B, Hermine O, Harriague J, Baleux F, Arenzana-Seisdedos F, Bachelerie F, Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling, J. Clin. Invest. 2008 Mar;118(3):1074-84.
• 2007
  Ruiz-Argüello MB, Smith VP, Campanella GS, Baleux F, Arenzana-Seisdedos F, Luster AD, Alcami A, An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain, J. Virol. 2008 Jan;82(2):917-26.
• 2007
  Laguri C, Sadir R, Rueda P, Baleux F, Gans P, Arenzana-Seisdedos F, Lortat-Jacob H, The novel CXCL12gamma isoform encodes an unstructured cationic domain which regulates bioactivity and interaction with both glycosaminoglycans and CXCR4, PLoS ONE 2007;2(10):e1110.
• 2007
  Wyler E, Kaminska M, Coïc YM, Baleux F, Véron M, Agou F, Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO, Protein Sci. 2007 Sep;16(9):2013-22.
• 2005
  Coïc YM, Vincent M, Gallay J, Baleux F, Mousson F, Beswick V, Neumann JM, de Foresta B, Single-spanning membrane protein insertion in membrane mimetic systems: role and localization of aromatic residues, Eur. Biophys. J. 2005 Dec;35(1):27-39.
• 2005
  Lorin C, Saidi H, Belaid A, Zairi A, Baleux F, Hocini H, Bélec L, Hani K, Tangy F, The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro, Virology 2005 Apr;334(2):264-75.
• 2005
  Bélot F, Guerreiro C, Baleux F, Mulard LA, Synthesis of two linear PADRE conjugates bearing a deca- or pentadecasaccharide B epitope as potential synthetic vaccines against Shigella flexneri serotype 2a infection, Chemistry 2005 Feb;11(5):1625-35.
• 2004
  Balabanian K, Harriague J, Décrion C, Lagane B, Shorte S, Baleux F, Virelizier JL, Arenzana-Seisdedos F, Chakrabarti LA, CXCR4-tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes, J. Immunol. 2004 Dec;173(12):7150-60.
• 2004
  Balabanian K, Lagane B, Pablos JL, Laurent L, Planchenault T, Verola O, Lebbe C, Kerob D, Dupuy A, Hermine O, Nicolas JF, Latger-Cannard V, Bensoussan D, Bordigoni P, Baleux F, Le Deist F, Virelizier JL, Arenzana-Seisdedos F, Bachelerie F, WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12, Blood 2005 Mar;105(6):2449-57.
• 2004
  Rao RM, Betz TV, Lamont DJ, Kim MB, Shaw SK, Froio RM, Baleux F, Arenzana-Seisdedos F, Alon R, Luscinskas FW, Elastase release by transmigrating neutrophils deactivates endothelial-bound SDF-1alpha and attenuates subsequent T lymphocyte transendothelial migration, J. Exp. Med. 2004 Sep;200(6):713-24.
• 2004
  Sadir R, Imberty A, Baleux F, Lortat-Jacob H, Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV, J. Biol. Chem. 2004 Oct;279(42):43854-60.
• 2004
  Wright K, Guerreiro C, Laurent I, Baleux F, Mulard LA, Preparation of synthetic glycoconjugates as potential vaccines against Shigella flexneri serotype 2a disease, Org. Biomol. Chem. 2004 May;2(10):1518-27.
• 2004
  Bartolomé RA, Gálvez BG, Longo N, Baleux F, Van Muijen GN, Sánchez-Mateos P, Arroyo AG, Teixidó J, Stromal cell-derived factor-1alpha promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities, Cancer Res. 2004 Apr;64(7):2534-43.
• 2003
  Balabanian K, Couderc J, Bouchet-Delbos L, Amara A, Berrebi D, Foussat A, Baleux F, Portier A, Durand-Gasselin I, Coffman RL, Galanaud P, Peuchmaur M, Emilie D, Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus, J. Immunol. 2003 Mar;170(6):3392-400.
• 2002
  Chanel C, Staropoli I, Baleux F, Amara A, Valenzuela-Fernandez A, Virelizier JL, Arenzana-Seisdedos F, Altmeyer R, Low levels of co-receptor CCR5 are sufficient to permit HIV envelope-mediated fusion with resting CD4 T cells, AIDS 2002 Nov;16(17):2337-40.
• 2002
  Mousson F, Coïc YM, Baleux F, Beswick V, Sanson A, Neumann JM, Deciphering the role of individual acyl chains in the interaction network between phosphatidylserines and a single-spanning membrane protein, Biochemistry 2002 Nov;41(46):13611-6.
• 2002
  Jamin N, Coïc YM, Landon C, Ovtracht L, Baleux F, Neumann JM, Sanson A, Most of the structural elements of the globular domain of murine prion protein form fibrils with predominant beta-sheet structure, FEBS Lett. 2002 Oct;529(2-3):256-60.
• 2002
  Valenzuela-Fernández A, Planchenault T, Baleux F, Staropoli I, Le-Barillec K, Leduc D, Delaunay T, Lazarini F, Virelizier JL, Chignard M, Pidard D, Arenzana-Seisdedos F, Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4, J. Biol. Chem. 2002 May;277(18):15677-89.
• 2002
  Balabanian K, Foussat A, Bouchet-Delbos L, Couderc J, Krzysiek R, Amara A, Baleux F, Portier A, Galanaud P, Emilie D, Interleukin-10 modulates the sensitivity of peritoneal B lymphocytes to chemokines with opposite effects on stromal cell-derived factor-1 and B-lymphocyte chemoattractant, Blood 2002 Jan;99(2):427-36.
• 2001
  Mousson F, Beswick V, Coïc YM, Baleux F, Huynh-Dinh T, Sanson A, Neumann JM, Concerted influence of key amino acids on the lipid binding properties of a single-spanning membrane protein: NMR and mutational analysis, Biochemistry 2001 Aug;40(33):9993-10000.
• 2001
  Valenzuela-Fernández A, Palanche T, Amara A, Magerus A, Altmeyer R, Delaunay T, Virelizier JL, Baleux F, Galzi JL, Arenzana-Seisdedos F, Optimal inhibition of X4 HIV isolates by the CXC chemokine stromal cell-derived factor 1 alpha requires interaction with cell surface heparan sulfate proteoglycans, J. Biol. Chem. 2001 Jul;276(28):26550-8.
• 2001
  Foussat A, Balabanian K, Amara A, Bouchet-Delbos L, Durand-Gasselin I, Baleux F, Couderc J, Galanaud P, Emilie D, Production of stromal cell-derived factor 1 by mesothelial cells and effects of this chemokine on peritoneal B lymphocytes, Eur. J. Immunol. 2001 Feb;31(2):350-9.
• 2000
  Sadir R, Baleux F, Grosdidier A, Imberty A, Lortat-Jacob H, Characterization of the stromal cell-derived factor-1alpha-heparin complex, J. Biol. Chem. 2001 Mar;276(11):8288-96.
• 2000
  Dat MH, Behr C, Jouin H, Baleux F, Mercereau-Puijalon O, Dubois P, Mimicking a conformational B cell epitope of the heat shock protein PfHsp70-1 antigen of Plasmodium falciparum using a multiple antigenic peptide, Parasite Immunol. 2000 Nov;22(11):535-43.
• 2000
  Montes M, Tagieva NE, Heveker N, Nahmias C, Baleux F, Trautmann A, SDF-1-induced activation of ERK enhances HIV-1 expression, Eur. Cytokine Netw. 2000 Sep;11(3):470-7.
• 2000
  Grabovsky V, Feigelson S, Chen C, Bleijs DA, Peled A, Cinamon G, Baleux F, Arenzana-Seisdedos F, Lapidot T, van Kooyk Y , Lobb RR, Alon R, Subsecond induction of alpha4 integrin clustering by immobilized chemokines stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions, J. Exp. Med. 2000 Aug;192(4):495-506.
• 2000
  Tilton B, Ho L, Oberlin E, Loetscher P, Baleux F, Clark-Lewis I, Thelen M, Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes, J. Exp. Med. 2000 Aug;192(3):313-24.
• 2000
  Lazarini F, Casanova P, Tham TN, De Clercq E, Arenzana-Seisdedos F, Baleux F, Dubois-Dalcq M, Differential signalling of the chemokine receptor CXCR4 by stromal cell-derived factor 1 and the HIV glycoprotein in rat neurons and astrocytes, Eur. J. Neurosci. 2000 Jan;12(1):117-25.
• 1999
  Blanpain C, Doranz BJ, Vakili J, Rucker J, Govaerts C, Baik SS, Lorthioir O, Migeotte I, Libert F, Baleux F, Vassart G, Doms RW, Parmentier M, Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein, J. Biol. Chem. 1999 Dec;274(49):34719-27.
• 1999
  Amara A, Lorthioir O, Valenzuela A, Magerus A, Thelen M, Montes M, Virelizier JL, Delepierre M, Baleux F, Lortat-Jacob H, Arenzana-Seisdedos F, Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine, J. Biol. Chem. 1999 Aug;274(34):23916-25.
• 1998
  Guerois R, Cordier-Ochsenbein F, Baleux F, Huynh-Dinh T, Neumann JM, Sanson A, A conformational equilibrium in a protein fragment caused by two consecutive capping boxes: 1H-, 13C-NMR, and mutational analysis, Protein Sci. 1998 Jul;7(7):1506-15.
• 1998
  Cordier-Ochsenbein F, Guerois R, Baleux F, Huynh-Dinh T, Lirsac PN, Russo-Marie F, Neumann JM, Sanson A, Exploring the folding pathways of annexin I, a multidomain protein. I. non-native structures stabilize the partially folded state of the isolated domain 2 of annexin I, J. Mol. Biol. 1998 Jun;279(5):1163-75.
• 1998
  Caruz A, Samsom M, Alonso JM, Alcami J, Baleux F, Virelizier JL, Parmentier M, Arenzana-Seisdedos F, Genomic organization and promoter characterization of human CXCR4 gene, FEBS Lett. 1998 Apr;426(2):271-8.
• 1998
  Bandres JC, Wang QF, O'Leary J, Baleaux F, Amara A, Hoxie JA, Zolla-Pazner S, Gorny MK, Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation, J. Virol. 1998 Mar;72(3):2500-4.
• 1998
  Guijarro JI, Djavadi-Ohaniance L, Baleux F, Delepierre M, Goldberg ME, Does a peptide bound to a monoclonal antibody always adopt a unique conformation?, Res. Immunol. 1998 Feb;149(2):127-37.
• 1998
  Dumonceaux J, Nisole S, Chanel C, Quivet L, Amara A, Baleux F, Briand P, Hazan U, Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype, J. Virol. 1998 Jan;72(1):512-9.
• 1996
  Beswick V, Baleux F, Huynh-Dinh T, Képès F, Neumann JM, Sanson A, NMR conformational study of the cytoplasmic domain of the canine Sec61 gamma protein from the protein translocation pore of the endoplasmic reticulum membrane, Biochemistry 1996 Nov;35(47):14717-24.
• 1996
  Cordier-Ochsenbein F, Guerois R, Baleux F, Huynh-Dinh T, Chaffotte A, Neumann JM, Sanson A, Folding properties of an annexin I domain: a 1H-15N NMR and CD study, Biochemistry 1996 Aug;35(32):10347-57.
• 1996
  Rodriguez MS, Wright J, Thompson J, Thomas D, Baleux F, Virelizier JL, Hay RT, Arenzana-Seisdedos F, Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo, Oncogene 1996 Jun;12(11):2425-35.
• 1996
  Jacqué JM, Fernández B, Arenzana-Seisdedos F, Thomas D, Baleux F, Virelizier JL, Bachelerie F, Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes, J. Virol. 1996 May;70(5):2930-8.
• 1996
  Roff M, Thompson J, Rodriguez MS, Jacque JM, Baleux F, Arenzana-Seisdedos F, Hay RT, Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo, J. Biol. Chem. 1996 Mar;271(13):7844-50.
• 1995
  Guijarro JI, González-Pastor JE, Baleux F, San Millán JL, Castilla MA, Rico M, Moreno F, Delepierre M, Chemical structure and translation inhibition studies of the antibiotic microcin C7, J. Biol. Chem. 1995 Oct;270(40):23520-32.
• 1995
  Odaert B, Baleux F, Huynh-Dinh T, Neumann JM, Sanson A, Nonnative capping structure initiates helix folding in an annexin I fragment. A 1H NMR conformational study, Biochemistry 1995 Oct;34(39):12820-9.
• 1995
  Tokatlidis K, Friguet B, Deville-Bonne D, Baleux F, Fedorov AN, Navon A, Djavadi-Ohaniance L, Goldberg ME, Nascent chains: folding and chaperone interaction during elongation on ribosomes, Philos. Trans. R. Soc. Lond., B, Biol. Sci. 1995 Apr;348(1323):89-95.
• 1995
  Navon A, Schulze AJ, Guillou Y, Zylinski CA, Baleux F, Expert-Bezançon N, Friguet B, Djavadi-Ohaniance L, Goldberg ME, Importance of residues 2-9 in the immunoreactivity, subunit interactions, and activity of the beta 2 subunit of Escherichia coli tryptophan synthase, J. Biol. Chem. 1995 Mar;270(9):4255-61.
• 1993
  Macquaire F, Baleux F, Huynh-Dinh T, Rouge D, Neumann JM, Sanson A, Proton NMR conformational study of an annexin I fragment: influence of a phospholipidic micellar environment, Biochemistry 1993 Jul;32(28):7244-54.
• 1992
  Baleux F, Dubois P, Novel version of Multiple Antigenic Peptide allowing incorporation on a cysteine functionalized lysine tree, Int. J. Pept. Protein Res. 1992 Jul;40(1):7-12.
• 1992
  Macquaire F, Baleux F, Giaccobi E, Huynh-Dinh T, Neumann JM, Sanson A, Peptide secondary structure induced by a micellar phospholipidic interface: proton NMR conformational study of a lipopeptide, Biochemistry 1992 Mar;31(9):2576-82.
• 1992
  Macquaire F, Baleux F, Huynh-Dinh T, Neumann JM, Sanson A, 1H-NMR conformational study of a synthetic peptide derived from the consensus sequence of annexins, Int. J. Pept. Protein Res. 1992 Feb;39(2):117-22.
• 1991
  Delepierre M, Larvor MP, Baleux F, Goldberg ME, 1H-NMR conformational analysis of a high-affinity antigenic 11-residue peptide from the tryptophan synthase beta 2 subunit, Eur. J. Biochem. 1991 Nov;201(3):681-93.
• 1991
  Larvor MP, Djavadi-Ohaniance L, Friguet B, Baleux F, Goldberg ME, Peptide/antibody recognition: synthetic peptides derived from the E. coli tryptophan synthase beta 2 subunit interact with high affinity with an anti-beta 2 monoclonal antibody, Mol. Immunol. 1991 Apr-May;28(4-5):523-31.
• 1989
  Harshman S, Alouf JE, Siffert O, Baleux F, Reaction of staphylococcal alpha-toxin with peptide-induced antibodies, Infect. Immun. 1989 Dec;57(12):3856-62.
• 1989
  Cochet M, Casrouge A, Dumont AM, Transy C, Baleux F, Maloy WL, Coligan JE, Cazenave PA, Kourilsky P, A new cell surface molecule closely related to mouse class I transplantation antigens, Eur. J. Immunol. 1989 Oct;19(10):1927-31.
• 1977
  Neĭmark II, [Injuries and diseases of the diaphragm], Khirurgiia (Mosk) 1977 May;(5):84-8.